Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by gottahunchon Dec 31, 2019 5:26pm
304 Views
Post# 30507130

RE:RE:Vinny - What's Your Call For Jan 14th

RE:RE:Vinny - What's Your Call For Jan 14thGood evening and happy new year to all.
As for the q end, last time we did 126M, which was 95 M distribution & 30 NET cannabis revenue. I thought it would be a little higher that it was but I believe it was discussed on the conference call CC Pharma was lower because of exchange rates and one time costs in changes to their systems. Hopefully we are closer to 100 M CC Pharma. Last q we had Alefia fooling around with our contract. I'm not clear on if our product was returned and sent back out at a higher price within the q, or not sent to them at all. This time we have no Alefia BS, and we continue to pick up market share:   https://www.reddit.com/r/weedstocks/comments/ei3yml/emdeems_q4_2019_estimates_for_ocs_dried_flower/

I think 40M is doable. Hopefully we come in close to 140 M. Each q will get better from here. With news on edibles, rec 2.0 products, euro supply deals and good earnings, short covering could shoot us to $10 quickly. I'm definitely a believer in $20 for 2020.

Vinny57 wrote: I'll take this one, and may I say I am in agreement on most of what you say on here (along with Gottahunch).  So I believe, as you say, that the needle won't really start to move "until July or (especially) October earnings". I'll drop you price range a bit to $7-$8 for the end of Jan. ,  $8-$10 for April  , But....$15-$20 for year end.  October should be huge in comparison.  As far as the 14th., $125-$140 mil. Anything more would be a very surprising bonus.

Happy New Year to all the steadfast Aphrian 'longs'........ 2020 will be our year!

CentreIce24 wrote: Hey Vinny
What's your call for Jan 14th?
Not sure what to think when you take into consideration the other LP's most recent stinky earning reports and the current funk the cannabis sector is currently going through.
I'm not expecting anything earth shattering but should be solid, similar to last quarter.
I think the same goes for April's earning report, nothing outstanding but solid again.
My thoughts are you won't see the needle really start to move until July or October earnings and that is if we keep executing.
Thinking our share price could be in the $8-$9 cdn range by the end of January, $10 - $12 cdn end of April and in the $15 - $18 cdn by the end of October. 

Happy New Year
Best,
CentreIce



 




Bullboard Posts